Kura Oncology, Inc.

KURA ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2017

Total Assets: $95.9M

Liabilities Breakdown FY2017

Total Liabilities: $16.0M